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Abstract
Objectives
To evaluate whether urodynamic investigation (UDI), the gold standard to assess refractory
lower urinary tract symptoms (LUTS), is appropriate to select healthy volunteers with
apparent normal lower urinary tract function as control subjects for comparative studies.
Subjects and Methods
42 healthy subjects (22 women, mean age 32±10 years; 20 men, mean age 37±12 years)
without LUTS were included into this prospective single-centre cohort study. All subjects
recorded a 3-day bladder diary, completed validated questionnaires regarding LUTS, and
underwent neuro-urological assessment as well as free uroflowmetry. Same session repeat
UDI was performed according to “Good Urodynamic Practice” recommended by the Inter-
national Continence Society, but using an air-charged instead of a water-filled catheter,
and evaluated by a blinded investigator.
Results
All 3-day bladder diaries, LUTS questionnaires, neuro-urological assessments and free
uroflowmetries were within normal limits. Overall (either during the first or second UDI),
same session repeat UDI revealed pathological findings in 71% (30/42): Detrusor overac-
tivity was detected in 14% (3/22) and 30% (6/20), post void residual >100mL in 14%
(3/22) and 25% (5/20), bladder outlet obstruction in 9% (2/22) and 20% (4/20) and detrusor
sphincter dyssynergia in 77% (17/22) and 65% (13/20) of our women and men,
respectively.
Repeatability of detrusor overactivity (κ = 0.78, 95% CI: 0.54–1.02) and detrusor sphinc-
ter dyssynergia (κ = 0.77, 95% CI: 0.55–0.98) showed substantial agreement between both
UDIs. All other assessed urodynamic parameters had wide 95% limits of agreement for dif-
ferences in the parameters indicating poor repeatability.
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Conclusions
More than 70% of our healthy subjects showed pathological urodynamic findings. Although
UDI is the gold standard to assess refractory LUTS, it seems not to be applicable in healthy
subjects to define normal lower urinary tract function. Therefore, we do not recommend
using UDI to select healthy control subjects.
Introduction
Urodynamic investigation (UDI) is the gold standard to assess refractory lower urinary tract
symptoms (LUTS), i.e. to detect lower urinary tract dysfunction (LUTD) [1]. However, patients
with LUTS do not necessarily show pathological urodynamic findings [2]. In general, knowl-
edge of what constitutes a normal organ function is based on investigation of healthy subjects.
However, previous UDIs in symptom-free healthy subjects showed a wide range of urodynamic
findings including pathological results [3–6]. Thus, the value of UDIs in asymptomatic sub-
jects, i.e. subjects without LUTS, is largely unknown.
The aim of the present study was to assess whether UDI (filling cystometry and pressure-
flow study (PFS)), is appropriate to select healthy volunteers, with apparent normal lower uri-
nary tract function, as control subjects for comparative studies with patients suffering from
LUTD.
Subjects and Methods
Ethics
This prospective cohort study has been approved by the local ethics committee (Kantonale
Ethikkommission Zürich, KEK-ZH-Nr. 2011–0346), is registered at ClinicalTrials.gov
(NCT01768910) and was performed at a single university spinal cord injury centre.
Subjects
Healthy subjects (22 women, mean age 32±10 years; 20 men, mean age 37±12 years) were
recruited by public advertisement. Inclusion criteria were: (1) age between 18 and 55 years, (2)
no LUTS, (3) no history of previous lower urinary tract surgery, (4) no history of previous or
current neurological diseases, including diabetic neuropathy, and (5) no current medication.
The flowchart of all visits can be found in Fig 1. During screening visit, healthy subjects were
informed about the study details, i.e. aims, methods, possible risks, and side effects. After
obtaining written informed consent, the following data was acquired: 3-day bladder diary and
validated, standardised questionnaires (in German language) regarding LUTS, quality of life
(QoL), mental status and depression, i.e. International Consultation on Incontinence Modular
Questionnairemodules (ICIQ-FUTS, ICIQ-MLUTS) [7], the Overactive Bladder Question-
naire short-form (OAB-q SF) [8], the Mini Mental Status Examination [9], and the Hospital
Anxiety and Depression Scale [10]. The scores for ICIQ-FLUTS were derived according to the
publication by Brookes et al. [11] and subdivided in filling, voiding, and incontinence symp-
toms. For ICIQ-MLUTS, the recommendation by the ICS was followed subdividing the scores
in voiding and incontinence symptoms [12]. Neuro-urological assessment [13] includedmedi-
cal history, examination of urogenital sensation, bulbocavernosus reflex (performed by squeez-
ing the clitoris or glans during digito-rectal examination and pelvic floor electromyography
(EMG)), anal reflex, anal sphincter tone, and anal squeeze response. Free uroflowmetrywas
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performed (uroflowmetryhas been repeated in case of voided volume<200 mL) and post void
residual (PVR) was measured by ultrasound. Prior to invasive UDI, urinary tract infection
(UTI) and pregnancy have been excluded. Subjects were instructed to reduce their fluid intake
two hours before the UDI. As a requirement of the local ethics committee, healthy subjects
obtained a minimal financial compensation.
Urodynamic investigation
UDIs were performed by two examiners (LL and MW) and comprised same session repeat fill-
ing cystometry and PFS. UDI was performed according to “Good Urodynamic Practice” rec-
ommended by the ICS [1] but using an air-charged instead of a water-filled catheter. No
minimal amplitude threshold to define detrusor overactivity was set. Bladder outlet obstruction
was defined according to Defreitas et al. [14] as maximum flow rate (Qmax)<12mL/s and
detrusor pressure (pDet) Qmax>25cmH2O or according to the Abrams-Griffiths nomogram
[15] for women and men, respectively. According to the recommendation of the ICS [16]
involuntary contraction of the urethral and/or periurethral striated muscle, i.e. elevated EMG
signal, during detrusor contraction, was defined as detrusor sphincter dyssynergia.
An air-charged, three-way 7 Fr transurethral catheter (T-DOC-7FD, LaborieMedical Tech-
nologies, Ontario, Canada) and a common rectal catheter for simultaneous measurements of
vesical and abdominal pressure were used. Both catheters were attached to the body surface,
using tape to assure correct placement during the entire UDI. The vesical catheter was attached
close to the urethral meatus to avoid expelling during UDI. Surface electrodes (Neotrode II,
ConMed Cooperation,New York, USA) were placed bilaterally around the external anal
sphincter to record activity of the pelvic floor, i.e. EMG. For comparison reasons between
women and men, free uroflowmetry, filling cystometry, and PFS were performed in sitting
position in all subjects, even if standing was the indicated preferred voiding position in some
male volunteers. During invasive UDI intravesical pressure, intraabdominal pressure, pDet,
pelvic floor EMG as well as urinary flow (Q), and voided volume in the voiding phase, using
Fig 1. Flow chart of all visits. On subjects’ request UDI could be performed at the first visit, if the 3-day bladder diary was already
available and all further inclusion criteria were met. LUTS = Lower urinary tract symptoms, PVR = Post void residual, UDI = Urodynamic
investigation.
doi:10.1371/journal.pone.0163847.g001
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Laborie Goby and LaborieUrocap IV system (LaborieMedical Technologies, Ontario, Can-
ada), were continuously recorded. Prior to each measurement, proper placement and function
of catheters and electrodeswere assessed by cough, pelvic floor contraction and elicitation of
the bulbocavernosus reflex. In addition, subjects were asked to cough during cystometry, i.e.
after every 100 mL, to verify correct placement and function of catheters. Moreover, plausibility
and quality control of clinical and urodynamic data was performed:Healthy volunteers
reported their sensation during investigations and free uroflowmetry and flow patterns during
PFS has been compared.
Continuous bladder filling was carried out using body warm (37°C) sterile saline at a filling
speed of 30 mL per minute for filling cystometry. Subjects were asked to report the following
sensations: first sensation of bladder filling (FSF), first desire to void (FDV) and strong desire
to void (SDV) during bladder filling when perceived, the infused volume at each time point
was acquired and correction for permanent urine self-productionwas made for maximum
cystometric capacity (MCC). Permission to void was given, when SDV was reported and PFS
was performed in privacy (i.e. no investigator in the room). After PFS, PVR was measured fol-
lowing bladder emptying by a single use 10 Fr transurethral catheter (LoFric Origo/Sense,
Wellspect HealthCare, Mölndal, Sweden). MCC was defined as the sum of voided volume and
PVR. If no micturition could be initiated, the whole catheterised volume was classified as PVR.
Subjects were blinded to UDI parameters and findings.
UDIs were assessed by a blinded investigator (US), i.e. an experienced consultant in neuro-
urology. The investigator had no knowledge of subjects’ history and clinical examination. Gen-
der only was unmasked to address the different definitions of bladder outlet obstruction.UDIs
were presented to the investigator in a randomised order mixed with patients suffering from
LUTS in a 1:1 ratio.
Statistical analysis
Data distribution was tested by Q-Q plots. Approximately normally distributed data (FSF,
FDV, SDV, MCC, compliance, pDet max during voiding, pDet Qmax, and voided volume)
were presented as mean ± standard deviation (SD), skewed data (pDet max during storage and
PVR) as median and interquartile range. Comparing unrelated samples, i.e. women vs. men,
the unpaired t test was used for approximately normally distributed data and the Mann-Whit-
ney U test for skewed data, respectively. For comparison of unrelated binary data Fisher’s exact
test was used.
To compare the difference between quantitative parameters between the first and second
UDI, i.e. repeatability, the generally accepted Bland and Altman 95% limits of agreement [17]
were applied (and therefore no p-values are given). The κ statistic was used to investigate agree-
ment of the presence or absence of detrusor overactivity and detrusor sphincter dyssynergia
between both UDIs.
Statistical analyses were performed using IBM's Statistical Package for the Social Sciences
(SPSS) V22 (IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY, USA) with p<0.05
considered statistically significant.
Results
Baseline characteristics
Baseline characteristics of the 42 subjects (22 women and 20 men, all Caucasians) are shown in
Table 1. Medical history, 3-day bladder diaries, questionnaires regarding LUTS and QoL,
neuro-urological assessment, free uroflowmetry, PVR, and urine samples, were without patho-
logical findings in all subjects.
Urodynamic Investigation in Healthy Volunteers
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Same session repeat urodynamic investigations
Urodynamic findings are shown in Table 2. Significant differences were found between genders
for volumes at FSF, pDet Qmax and Qmax within first and second UDI as well as for maxi-
mum pDet during the first PFS within first UDI. Overall, UDI revealed pathological findings
(Table 3, Figs 2 and 3) in 71% (30/42): Detrusor overactivity (p = 0.18) was detected in 14% (3/
22, 1 reported synchronous urgency) and 30% (6/20, 3 reported synchronous urgency), bladder
Table 1. Baseline characteristics.
Baseline characteristics Women Men p Value
(n = 22) (n = 20)
Age [year] 32 ± 10 37 ± 12 0.13†
18–39 years 15/22 (68%) 12/20 (60%)
40–55 years 7/22 (32%) 8/20 (40%)
Weight [kg] 61 ± 7 76 ± 6 <0.01**/†
3-day bladder diary
Micturition frequency per 24 hours 5.7 ± 1.2 5.9 ± 1.2 0.44†
Micturition volume per micturition [mL] 305 ± 110 305 ± 65 0.95†
Fluid intake per 24 hours [mL] 1920 ± 790 2230 ± 775 0.21†
Questionnaires
ICIQ-FLUTS/MLUTS***
Filling symptoms 1.1 ± 0.9 -
Voiding symptoms 0.2 ± 0.4 3 ± 2.8
Incontinence symptoms 0.3 ± 0.8 1.4 ± 2.5
OAB-q SF
Symptoms 6.9 ± 1.2 7.6 ± 1.6 0.18†
QoL 14.1 ± 0.9 13.9 ± 0.9 0.64†
HADS
Anxiety 2.8 ± 2.2 1.4 ± 1.5 0.01**/†
Depression 1 ± 1.5 1.1 ± 1.5 0.92†
MMSE 29.6 ± 0.5 29.7 ± 0.6 0.45†
Neuro-urological examination
Urogenital sensation (intact/impaired) 22/0 20/0
Bulbocavernosus reflex (intact/impaired) 22/0 20/0
Anal reflex (intact/impaired) 22/0 20/0
Anal sphincter tone (intact/impaired) 22/0 22/0
Anal squeeze response (intact/impaired) 22/0 20/0
Free uroflowmetry (Voided volume > 200 mL)
Maximum flow rate [mL/s] 29 ± 11 25 ± 6 0.12†
Post void residual [mL]* 0 (0–0) 0 (0–0) 0.18††
* = parameter with a skewed distribution (presented as median and interquartile range); all other parameters are approximately normally distributed
(presented as mean ± standard deviation)
** = significant difference between gender using an unpaired t test
*** = due to the different scoring systems, female and male subjects have not been compared
†
= unpaired t test
††
= Mann-Whitney U test
ICIQ = International Consultation on Incontinence Modular Questionnaire, FLUTS = Female lower urinary tract symptoms, MLUTS = Male lower urinary
tract symptoms, OAB-q SF = The Overactive Bladder Questionnaire short-form, QoL = Quality of life, HADS = Hospital Anxiety and Depression Scale,
MMSE = Mini-Mental State Examination.
doi:10.1371/journal.pone.0163847.t001
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outlet obstruction (p = 0.29) in 9% (2/22) and 20% (4/20), detrusor sphincter dyssynergia
(p = 0.3) in 77% (17/22) and 65% (13/20), and PVR>100mL (p = 0.29) in 14% (3/22) and 25%
(5/20) of our women and men, respectively. Pathological findings were similar during both
UDIs (p>0.05).
Using the Bland and Altman method, there were wide 95% limits of agreement for differ-
ences in same session UDI parameters indicating poor repeatability (Figs 4 and 5).
Detrusor overactivity and detrusor sphincter dyssynergia were found in 9 (21%) versus 8
(19%) and in 30 (71%) versus 30 (71%) of the 42 subjects in UDI 1 versus 2, respectively. The
repeatability of detecting detrusor overactivity (κ = 0.78, 95% CI 0.54–1.02) and detrusor
sphincter dyssynergia (κ = 0.77, 95% CI 0.55–0.98) showed substantial agreement between
both UDIs.
Adverse events
An adverse event, as defined by the International Conference on Harmonisation (ICH) Good
Clinical Practice (GCP) Guidelines (E6) [18] and International Organization for Standardiza-
tion (ISO, 14155) [19], did not occur.
Discussion
Main findings
In more than 70% of our healthy subjects UDI revealed pathological findings,most commonly
detrusor sphincter dyssynergia defined as a detrusor contraction concurrent with an involun-
tary contraction of the urethral and/or periurethral striated muscle [16]. Although UDI is the
gold standard to assess refractory LUTS, it seems not to be applicable in apparently healthy
Table 2. Urodynamic findings.
First investigation Second investigation
Urodynamic parameter Women Men p Value Women Men p Value
Filling cystometry
FSF [mL] 75 ± 75 130 ± 85 0.04**/† 70 ± 85 145 ± 95 0.01**/†
FDV [mL] 235 ± 110 215 ± 105 0.53† 265 ± 115 235 ± 145 0.49†
SDV [mL] 465 ± 155 435 ± 140 0.49† 530 ± 165 450 ± 150 0.11†
MCC [mL] 560 ± 185 500 ± 165 0.27† 550 ± 160 500 ± 160 0.33†
Compliance [mL/cmH2O] 268 ± 204 241 ± 183 0.66† 300 ± 211 193 ± 195 0.1†
pDet max during storage [cmH2O]* 4 (3–7) 6 (2–12) 0.46†† 5 (2–8) 6 (3–11) 0.26††
Pressure flow study
pDet max during voiding [cmH2O] 46 ± 28 65 ± 25 0.03**/† 48 ± 24 62 ± 33 0.11†
pDet Qmax [cmH2O] 29 ± 11 51 ± 16 <0.01**/† 32 ± 16 47 ± 20 <0.01**/†
Qmax [mL/s] 29 ± 17 19 ± 8 0.02**/† 28 ± 12 20 ± 8 0.03**/†
Voided volume [mL] 510 ± 255 445 ± 190 0.36† 505 ± 185 450 ± 195 0.36†
PVR [mL]* 0 (0–15) 15 (0–105) 0.14†† 0 (0–5) 0 (0–60) 0.21††
* = parameter with a skewed distribution (presented as median and interquartile range); all other parameters are approximately normally distributed
(presented as mean ± standard deviation)
** = significant difference between gender using an unpaired t test
†
= unpaired t test
††
= Mann-Whitney U test
FSF = First sensation of filling, FDV = First desire to void, SDV = Strong desire to void, MCC = Maximum cystometric capacity, pDet max = Maximum
detrusor pressure, pDet Qmax = Detrusor pressure at maximum flow rate, Qmax = Maximum flow rate, PVR = Post void residual.
doi:10.1371/journal.pone.0163847.t002
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subjects to define normal lower urinary tract function. Therefore, we do not recommend using
UDI to select healthy subjects as controls for comparative studies.
Findings in the context of existing evidence
The literature on UDI findings in healthy subjects is very limited. In line with previous studies
[5, 6, 20], we found significantly lower bladder volumes at FSF in women compared to men. In
contrast to other studies, the volumes at FSF were relatively low, what could be instruction
related, e.g. filling sensation versus awareness of the urethral catheter irritating the bladder
wall, as subjects were instructed to report the first bladder perception during filling cystometry.
However, as FSF is a very subjective sensation wide variability seems plausible. We also
detected significantly lower pDet during PFS and a higher Qmax in women compared to men,
i.e. phenomena well known fromUDI in patients with LUTS [14, 15]. In healthy volunteers,
involuntary detrusor contractions would be expected, but earlier studies revealed detrusor
overactivity in 4–18% during conventional and up to 69% during ambulatory urodynamics in
asymptomatic subjects [5, 21, 22]. It could be shown that the method of instruction, i.e. neither
try to void nor to inhibit micturition during bladder filling versus simply report sensation to
the examiner, affects the incidence of involuntary detrusor contractions [23]. Overall, detrusor
overactivity was detected in 21% of our healthy subjects. It was found more frequently in men
(30%) than in women (14%). The reason for this finding is unclear but anatomical gender dif-
ferences may be relevant as the catheter could irritate the urethral mucosa causing detrusor
overactivity during UDI. Lower bladder capacity in bladder diary compared to UDI might be
explained by the fact that in everyday life the bladder is also emptied on occasion and not only
Table 3. Pathological findings during urodynamic investigations.
First investigation Second investigation
Urodynamic parameter Women Men Women Men
Filling cystometry
Detrusor overactivity 14% (3/22) 30% (6/20) 14% (3/22) 25% (5/20)
Detrusor overactivity incontinence 14% (3/22) 5% (1/20) 0 0
Compliance < 20 [mL/cmH2O] 5% (1/22) 0 0 0
Pressure flow study
Micturition not possible 9% (2/22) 5% (1/20) 9% (2/22) 5% (1/20)
Obstructed* 9% (2/22) 10% (2/20) 9% (2/22) 20% (4/20)
Equivocal* - 20% (4/20) - 5% (1/20)
Detrusor sphincter dyssynergia 77% (17/22) 65% (13/20) 77% (17/22) 65% (13/20)
PVR >100 mL 14% (3/22) 25% (5/20) 5% (1/22) 20% (4/20)
No significant difference for appearance of pathological findings between gender was seen, using Fisher’s exact test for comparison of unrelated binary
data
Only one male patient showed detrusor overactivity during the first UDI but not during the second UDI, detrusor sphincter dyssynergia occurred each time in
the same patient. One female subject and one male subject could not void during both, the first and the second UDI. Two other female subjects could either
void during the first or second UDI, respectively. One female subject showed bladder outlet obstruction in PFS during both UDIs. Two other female subjects
showed bladder outlet obstruction in PFS either during the first or second UDI. The two male subjects with bladder outlet obstruction in PFS during the first
UDI showed also bladder outlet obstruction during the second UDI. The two male subjects with bladder outlet obstruction during the second UDI only were
equivocal during the first UDI.
*according to Defreitas et al. and the Abrams-Griffiths nomogram for women and men, respectively (due to the different definitions, female and male
subjects have not been compared)
PVR = Post void residual, PFS = Pressure flow study, UDI = Urodynamic investigation.
doi:10.1371/journal.pone.0163847.t003
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at SDV. Moreover, bladder volume effects and the non-physiological high filling rate (30 mL/s)
cannot be ruled out completely as an underlying cause for detrusor overactivity episodes.
Regarding parameters from the PFS, our values are in accordance with the very limited
available literature [3, 21].
In our cohort, detrusor sphincter dyssynergia was the most commonly detected pathological
finding. It might be argued, that detrusor sphincter dyscoordination or dysfunctional voiding
would be more appropriate terms than detrusor sphincter dyssynergia to describe our findings.
However, according to ICS terminology, detrusor sphincter dyssynergia is a pure urodynamic
diagnosis defined as detrusor contraction concurrent with an involuntary contraction of the
urethral and/or periurethral striated muscle and typically occurs in patients with a supra-sacral
lesion [16], but an underlying neurological disorder has not been a prerequisite for the defini-
tion. Indeed, a percentage of 71% (30/42) undetected underlying neurological disorders in pre-
sumably healthy volunteers is very unlikely. Considering the normal flow pattern and lack of
PVR during free uroflowmetry, the high rate of detrusor sphincter dyssynergia is most likely a
phenomenon provoked by the examination itself, i.e. stiff irrigating catheter and the unselective
recording of the surface EMG. Although detrusor sphincter dyscoordination is commonly
used in German speaking countries for detrusor sphincter dyssynergia in neurologically nor-
mal individuals, it is not according to the ICS terminology. Moreover, dysfunctional voiding is
not a very specific term defined as intermittent and/or fluctuating flow rate due to involuntary
Fig 2. Pathological findings during filling cystometry. Filling cystometry (bladder filling with 30 mL/min) of a 51 years old healthy man:
First detrusor overactivity occurs at 125 mL (red-dashed line) with maximum pDet of 54 cmH2O but no detrusor overactivity incontinence,
the maximum cystometric capacity is 345 mL. The associated pressure flow study is normal and not shown in the figure.
doi:10.1371/journal.pone.0163847.g002
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intermittent contractions of the periurethral striated muscle during voiding [16]. Importantly,
detrusor contraction is not considered by this definition.
Combined pelvic floor EMG and videocystourethrography during UDI are the most
accepted and widely agreedmethods for diagnosing detrusor sphincter dyssynergia [24]. In the
present study, however, we refrained from using videocystourethrography to avoid radiation
exposure to our healthy volunteers. Therefore, we only used pelvic floor EMG to record detru-
sor sphincter dyssynergia. In line with our findings, an increased EMG signal during voiding
has been reported in more than half of 321 neurologically normal female patients with predom-
inant stress urinary incontinence [25], not demonstrating the typically expected relaxation dur-
ing normal voiding. To distinguish between a solitary EMG activation of the intraurethral
striated sphincter and a general muscle activation of the pelvic floor, an intramural sphincter
Fig 3. Pathological findings during pressure flow study. a) Pressure flow study of a 24 years old healthy woman: The first spike
indicates a cough to evaluate correct catheter placement, thereafter permission to void (*) is obtained. The EMG signal during pressure
flow study is elevated, the flow is interrupted; consequent spikes in the vesical and detrusor pressure can be seen. Maximum cystometric
capacity/voided volume 395 mL, maximum pDet voiding 31 cmH2O at maximum flow rate 25 mL/s, no post void residual. b) The free
uroflowmetry in the same subject reveals a normal flow-curve. Maximum flow rate 30 mL/s, voided volume 390 mL, no post void residual. In
line with the International Continence Society, we interpret detrusor sphincter dyssynergia in this pressure flow study as a phenomenon
provoked by the examination itself, especially also considering the normal flow pattern and the lack of PVR during free uroflowmetry. * =
permission to void, EMG = electromyography, pAbd = intraabdominal pressure, pVes = intravesical pressure, pDet = detrusor pressure,
Qmax = maximum flow rate, V = volume.
doi:10.1371/journal.pone.0163847.g003
Urodynamic Investigation in Healthy Volunteers
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needle electrode EMG would have been needed.However, surface electrodes are used in daily
clinical practice and placing needle electrodes in healthy subjects would cause ethical concerns.
Repeatability of detrusor overactivity and detrusor sphincter dyssynergia showed substantial
agreement between both UDIs. For all other urodynamic parameters assessed, however, there
were wide 95% limits of agreement for differences in the parameters, indicating poor repeat-
ability. These findings are very similar to the results in patients with neurogenic LUTD [24, 26]
and highlight the importance of same session repeat UDI for clinical decisionmaking.
Implications for practice
The principal aim of a UDI is to detect and specify LUTD related to the patients’ symptoms
helping to select the most appropriate treatment. However, Katz et al. [2] reported discordance
between clinical and UDI findings in 45% of patients with storage, 25% with voiding and 54%
with combined storage and voiding problems, respectively. Although UDI did change clinical
decisionmaking and therapy in a relevant percentage of men with voiding dysfunction, it
remained unclear whether this also leads to reduced symptoms after treatment [27]. Based on
our study, identifying pathological findings in more than 70%, UDI seems not be appropriate
in healthy subjects to define normal lower urinary tract function. In patients complaining
about LUTS, a urodynamic pattern such as in Fig 2 would lead to the initiation of a treatment.
However, pathological urodynamic patterns may be iatrogenic, simply induced by the UDI
itself and not by an underlying disease. UDI is always a non-physiological attempt to mimic
storage and voiding phase and as such it is subject to many errors. In fact, in clinical practice
Fig 4. Difference against mean plot filling cystometry. Difference against mean plot for a) first sensation of filling, b) first desire to void,
c) strong desire to void, d) maximum cystometric capacity, e) compliance, and f) maximum detrusor pressure during filling for UDI 1 vs. 2.
Wide 95% limits of agreement reflect poor repeatability with unacceptable discrepancies between same session repeat UDIs.
UDI = Urodynamic investigation.
doi:10.1371/journal.pone.0163847.g004
Urodynamic Investigation in Healthy Volunteers
PLOS ONE | DOI:10.1371/journal.pone.0163847 October 13, 2016 10 / 15
we compare the Q shape of the free uroflowmetrywith the PFS and if the free flow Q trace is
normal we would disregard an eventual pathological flow pattern of the PFS and attribute it
may be secondary to the test situation. Further, social inhibition can be a reason for patients
not being able to void. According to the ICS, findings of PVR during invasive UDI should be
considered as an artefact caused by UDI, if no PVR is demonstrated after free uroflowmetry
[16]. If voiding symptoms are not the urodynamic question the UDI is being performed to
answer, such findingsmay be irrelevant in daily clinical practice. Thus, for clinical decision
making, it is crucial that UDI findings reflect the situation in daily life, i.e. the patients’ symp-
toms. Validated questionnaires and bladder diaries are of great value since they provide an
objective patient-reportedmeasure of LUTS [28].
Implications for research
In contrast to patients with LUTS, there is no consensus or standardisation regarding normal
UDI parameters and/or nomograms in healthy subjects.When applying generally agreed defi-
nitions [16], one will encounter a very high percentage of pathological findings. Therefore, we
do not recommend using UDI to select healthy subjects as controls for comparative studies but
rather rely on bladder diaries, validated questionnaires and neuro-urological assessment [13].
Detrusor sphincter dyssynergia was one of the predominant findings in our study. Intermittent
involuntary contraction of the urethral and/or periurethral striated muscle due to a contact
with the transurethral urodynamic catheter could have contributed to these findings. This may
also be relevant in patients with preserved sensory function [29]. Comparison between free
Fig 5. Difference against mean plot pressure flow study. Difference against mean plot for a) maximum detrusor pressure during
voiding, b) detrusor pressure at maximum flow-rate, c) maximum flow rate, d) voided volume, and e) post void residual for UDI 1 vs. 2. Wide
95% limits of agreement reflect poor repeatability with unacceptable discrepancies between same session repeat UDIs. UDI = Urodynamic
investigation.
doi:10.1371/journal.pone.0163847.g005
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uroflowmetry and invasive UDI both conducted with pelvic floor EMG could give further
insights into catheter-induced changes.
Thus, many important questions remain to be answered highly warranting further investi-
gations in healthy subjects.
Limitations of the study
Although to the best of our knowledge, this is the first prospective study to assess the value of
UDI to appropriately select healthy volunteers with apparent normal lower urinary tract func-
tion as control subjects, some limitations should be addressed. Since we used an air-charged
catheter for UDI, it is unclear whether the results can be extrapolated to UDI with a water-filled
catheter, especially considering that for urethral pressure measurement urodynamic catheters
cannot be used interchangeably because of insufficient agreement [30] and that this may also
be the case for cystometry and PFS. The response to pressure changes and the frequency rate of
attenuated signals are different between the air-charged and water-filled systems [31, 32].
Although there are no randomised controlled trials, higher pressures were consistently found
with the air-charged compared with the water-filled catheters [32, 33]. The Abrams-Griffiths
nomogram to define bladder outlet obstruction in men [15] has only been validated for water-
filled systems, but lacking alternatives we applied it also in our study, so that bladder outlet
obstructionmay have been overestimated. Considering the relative young age of the studied
cohort, a selection bias cannot be completely excluded. Based on age-related urodynamic
changes [34], it may be hypothesised that older subjects are more vulnerable for UDI-induced
pathological findings. Subsequently, an older population of healthy subjects could even show a
higher percentage of pathological results. Moreover, we used a constant filling rate of 30 mL/
min and did not explore a potential impact by changing the infusion speed betweenUDIs and/
or subjects. Taking into account that a physiological filling rate (mL/min) has been defined as
less than body weight in kg divided by 4 [16], we cannot exclude that a supra-physiological
infusion speedmight have provoked detrusor overactivity contributing to the high incidence of
detrusor overactivity found in our healthy volunteers. In addition, different bladder volumes in
free uroflowmetry and invasive UDI might be relevant and complicate comparability of these
parameters.
Conclusions
UDI is the gold standard to assess refractory LUTS, i.e. to detect LUTD. However, UDI is a
non-physiological examination and may result in investigation-induced pathological findings.
Indeed, in more than 70% of our healthy subjects, UDI revealed pathological findings, most
commonly detrusor sphincter dyssynergia. Thus, UDI seems not to be a sensible tool to define
normal lower urinary tract function and may result in exclusion of many potential candidates
due to false positive pathological findings. Based on the current study, we do not recommend
UDI to select healthy subjects as controls for comparative studies but rather rely on validated
questionnaires, bladder diaries, free uroflowmetry, PVR,medical history and physical
examination.
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